T. Whiteside

发表

Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.

T. Whiteside, R. Herberman, H. Rabinowich, 1991, Cellular immunology.

Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.

T. Whiteside, G. Mantovani, M. Bell, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity.

A. Tolcher, T. Whiteside, J. Stephenson, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.

Theresa, Whiteside, J. Kirkwood, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

C. Snyderman, J. Johnson, J. Bryant, 1993, Cancer research.

Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.

T. Whiteside, T. Whiteside, 1998, Advances in experimental medicine and biology.

Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.

T. Whiteside, R. Herberman, S. Iwatsuki, 1991, Cancer research.

Isolation, phenotyping, and functional analysis of lymphocytes from human liver.

D. V. van Thiel, T. Whiteside, R. Herberman, 1990, Clinical immunology and immunopathology.

Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.

P. Robbins, R. Herberman, R. Mailliard, 1998, Blood.

Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.

J. Johnson, T. Whiteside, D. Heo, 1987, Cancer research.

Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products.

C A Nicolette, D Healey, I Tcherepanova, 2007, Vaccine.

Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.

T. Whiteside, R. Herberman, H. Rabinowich, 1993, Journal of immunology.

Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation.

R. Jain, T. Whiteside, A. Sasaki, 1991, Journal of the National Cancer Institute.

Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.

J. Johnson, W. Lin, M. Lotze, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

T. Whiteside, R. Herberman, H. Rabinowich, 1992, Journal of immunology.

The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.

J. Johnson, T. Whiteside, R. Herberman, 1990, Cellular immunology.

Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.

M. Sacchi, T. Whiteside, Jonas T. Johnson, 1990, Cancer research.

Squamous Cell Carcinoma of the Head and Neck Human Cytotoxic T-Cell Lines with Restricted Specificity for Updated

D. Schwartz, T. Whiteside, R. Herberman, 2006 .

A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.

T. Whiteside, R. Melder, R. Herberman, 1988, Cancer research.

Interleukin 2 receptors on squamous cell carcinomas of the head and neck. Characterization and functional role.

E. Galeazzi, M. Sacchi, T. Whiteside, 1992, Acta Oto-Laryngologica.

Antiproliferative effects of cytokines on squamous cell carcinoma.

J. Johnson, T. Whiteside, I. Klapan, 1991, Archives of otolaryngology--head & neck surgery.

Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.

J. Johnson, T. Whiteside, T. Saito, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells.

R. Herberman, H. Rabinowich, M. Manciulea, 1996, Journal of immunology.

Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation.

W. Lin, T. Whiteside, A. Amoscato, 1995, Journal of immunology.

Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.

T. Whiteside, U. Nannmark, R. Herberman, 1996, Cancer research.

Hairy cell leukemia: a case with B-lymphocyte origin.

T. Whiteside, B. Rabin, R. Shadduck, 1977, American journal of clinical pathology.